Login
No login? Register now to unlock hella tokens
No login? Register now to unlock hella tokens
Log In person
Coherus BioSciences Inc logo
Coherus BioSciences Inc CHRS
summarize 1 total product line
calendar_month Revenue as of 12/31/2023
Reporting Segmentarrow_drop_up Product Line Amount (USD) Percentage
keyboard_arrow_right Reporting Segment & Product Line Amount (USD) Percentage
Immuno-oncology
Biosimilars; sold through distributor
These companies research, develop, and manufacture biosimilars, or biopharmaceutical products that are marketed as an alternative to other companies' products.
257.24M 100.00%
keyboard_arrow_right keyboard_arrow_down
Immuno-oncology
Biosimilars; sold through distributor
257.24M 100.00%
keyboard_arrow_right
These companies research, develop, and manufacture biosimilars, or biopharmaceutical products that are marketed as an alternative to other companies' products.